Maintenance window scheduled to begin at February 14th 2200 est. until 0400 est. February 15th

(e.g. yourname@email.com)

Forgot Password?

    Or login with Facebook
    Defense Visual Information Distribution Service Logo

    WRAIR starts phase I clinical trials for new COVID-19 vaccine participant interview

    Advanced Embed Example

    Add the following CSS to the header block of your HTML document.

    Then add the mark-up below to the body block of the same document.

    MD, UNITED STATES

    04.06.2021

    Video by Arlen Caplan and Mike Walters

    Walter Reed Army Institute of Research

    Francis Holinaty discusses his participation in WRAIR's Phase I clinical trial to test WRAIR's spike ferritin nanoparticle (SpFN) vaccine at the WRAIR Clinical Trials Center. Built on a ferritin platform, the vaccine offers a flexible approach to targeting multiple variants of the virus that causes COVID-19 and potentially other coronaviruses as well.

    LEAVE A COMMENT

    VIDEO INFO

    Date Taken: 04.06.2021
    Date Posted: 04.06.2021 17:33
    Category: Interviews
    Video ID: 789714
    VIRIN: 210406-A-LY492-001
    Filename: DOD_108267513
    Length: 00:05:30
    Location: MD, US

    Video Analytics


    Downloads: 5
    High-Res. Downloads: 5

    PUBLIC DOMAIN